# ISO 13485:2016 Quality Manual

## Symbion Medical Technologies
## Medical Devices - Quality Management Systems

**Document Number:** QM-001  
**Revision:** 1.0  
**Effective Date:** December 1, 2024  
**Next Review Date:** December 1, 2025

---

## DOCUMENT CONTROL

| Revision | Date | Description | Approved By |
|----------|------|-------------|-------------|
| 1.0 | 2024-12-01 | Initial Release | [CEO Name] |

---

## TABLE OF CONTENTS

1. [Introduction](#1-introduction)
2. [Scope](#2-scope)
3. [Quality Policy](#3-quality-policy)
4. [Quality Management System](#4-quality-management-system)
5. [Management Responsibility](#5-management-responsibility)
6. [Resource Management](#6-resource-management)
7. [Product Realization](#7-product-realization)
8. [Measurement, Analysis, and Improvement](#8-measurement-analysis-and-improvement)

---

## 1. INTRODUCTION

### 1.1 Company Information
- **Company Name:** Symbion Medical Technologies
- **Address:** [Company Address]
- **Registration Number:** [Business Registration]
- **Website:** www.symbion.health

### 1.2 Purpose
This Quality Manual describes the Quality Management System (QMS) implemented by Symbion Medical Technologies in accordance with ISO 13485:2016 requirements for the design, development, manufacture, and distribution of medical devices.

### 1.3 Product Scope
**Products Covered:**
- Symbion Gut-Brain Interface (GBI) Biosensor System
  - Hardware: Wearable biosensor device
  - Software: Mobile application and cloud backend
  - Accessories: Charging cables, user manual

**Device Classification:**
- FDA: Class II Medical Device
- EU MDR: Class IIa Medical Device
- Intended Use: In vitro diagnostic monitoring of gut neurotransmitters

---

## 2. SCOPE

### 2.1 ISO 13485:2016 Scope Statement
This Quality Manual applies to the design, development, production, storage, distribution, installation, and servicing of the Symbion GBI Biosensor System.

### 2.2 Exclusions
**Clause 7.6 - Control of Monitoring and Measuring Equipment:**
Partial exclusion - Symbion does not perform equipment calibration internally. All calibration is performed by external ISO/IEC 17025 accredited laboratories.

**Justification:** Symbion does not have in-house calibration capabilities. This exclusion does not affect the company's ability to provide safe and effective medical devices.

### 2.3 Regulatory Requirements
The QMS complies with:
- ISO 13485:2016
- 21 CFR Part 820 (FDA QSR)
- EU MDR 2017/745
- ISO 14971:2019 (Risk Management)
- IEC 62304:2006 (Medical Device Software)

---

## 3. QUALITY POLICY

### 3.1 Policy Statement
Symbion Medical Technologies is committed to:
- Designing and manufacturing safe, effective medical devices that meet customer and regulatory requirements
- Maintaining compliance with ISO 13485:2016 and applicable regulatory requirements
- Continually improving the effectiveness of our Quality Management System
- Ensuring patient safety is paramount in all activities
- Meeting or exceeding customer expectations

### 3.2 Quality Objectives
1. **Product Quality:** ≥99% of devices pass final inspection
2. **On-Time Delivery:** ≥95% of orders shipped within 5 business days
3. **Customer Satisfaction:** ≥90% customer satisfaction score
4. **Complaint Response:** 100% of complaints acknowledged within 24 hours
5. **CAPA Effectiveness:** ≥95% of CAPAs closed on time
6. **Non-Conformance Rate:** <2% of production batches

**Review:** Quality objectives reviewed annually by management.

### 3.3 Communication
This Quality Policy is:
- Communicated to all employees during onboarding
- Posted throughout the facility
- Reviewed annually at Management Review meetings
- Available to customers and regulatory authorities upon request

---

## 4. QUALITY MANAGEMENT SYSTEM

### 4.1 General Requirements (Clause 4.1)

#### 4.1.1 QMS Establishment
Symbion has established, documented, implemented, and maintains a QMS in accordance with ISO 13485:2016.

#### 4.1.2 Processes
The following processes have been identified:
- Management processes (planning, review, improvement)
- Resource management (personnel, infrastructure, environment)
- Product realization (design, purchasing, production, service)
- Measurement and monitoring (inspection, testing, audits)

#### 4.1.3 Outsourced Processes
| Process | Supplier | Control Method |
|---------|----------|----------------|
| PCB Assembly | [Contract Manufacturer] | Supplier audit, incoming inspection |
| Sterilization | [Sterilization Facility] | Certificate of Sterilization, validation |
| Software Hosting | [Cloud Provider] | SLA, security audits |
| Calibration | [Calibration Lab] | ISO/IEC 17025 accredited |

### 4.2 Documentation Requirements (Clause 4.2)

#### 4.2.1 Quality Manual
This document serves as the Quality Manual per ISO 13485:2016 Clause 4.2.1.

#### 4.2.2 Quality Management System Documentation
```
Level 1: Quality Manual (this document)
Level 2: Procedures (SOPs)
Level 3: Work Instructions
Level 4: Forms and Records
```

**Documented Procedures:**
- Document Control (SOP-001)
- Record Control (SOP-002)
- Management Review (SOP-003)
- Internal Audit (SOP-004)
- Corrective Action/Preventive Action (CAPA) (SOP-005)
- Product Design and Development (SOP-006)
- Risk Management (SOP-007)
- Purchasing and Supplier Management (SOP-008)
- Production and Process Controls (SOP-009)
- Inspection and Testing (SOP-010)
- Non-Conforming Product (SOP-011)
- Complaint Handling (SOP-012)
- Medical Device Reporting (SOP-013)
- Post-Market Surveillance (SOP-014)
- Traceability (SOP-015)

#### 4.2.3 Medical Device File (Design History File)
Maintained for Symbion GBI Biosensor:
- Design inputs and outputs
- Design verification and validation
- Design transfer
- Design changes and history

#### 4.2.4 Document Control (Clause 4.2.4)
**Procedure:** SOP-001 Document Control

**Controls include:**
- Approval before issue
- Review and update as necessary
- Current revision identification
- Availability at points of use
- Legibility and identifiability
- External documents identified and controlled
- Obsolete documents prevented from unintended use

**Document Numbering:**
- QM = Quality Manual
- SOP = Standard Operating Procedure
- WI = Work Instruction
- FORM = Form/Template
- REC = Record

#### 4.2.5 Record Control (Clause 4.2.5)
**Procedure:** SOP-002 Record Control

**Records maintained:**
- Management review
- Design and development
- Risk management
- Supplier evaluation
- Production and process controls
- Inspection and testing
- Non-conformances and CAPA
- Complaints and vigilance
- Training

**Retention:** Minimum 10 years from date of manufacture (or per regulatory requirement).

**Storage:** Electronic records in validated document management system with backup.

---

## 5. MANAGEMENT RESPONSIBILITY

### 5.1 Management Commitment (Clause 5.1)
Top management demonstrates commitment to QMS by:
- Establishing Quality Policy and Objectives
- Conducting Management Reviews
- Ensuring resource availability
- Communicating importance of regulatory and customer requirements

### 5.2 Customer Focus (Clause 5.2)
Management ensures:
- Customer requirements are determined and met
- Regulatory requirements are identified and implemented
- Customer satisfaction is monitored

### 5.3 Quality Policy (Clause 5.3)
See Section 3.1

### 5.4 Planning (Clause 5.4)

#### 5.4.1 Quality Objectives
See Section 3.2

#### 5.4.2 QMS Planning
- Annual quality plan developed
- Resources allocated per plan
- QMS integrity maintained during changes

### 5.5 Responsibility, Authority, and Communication (Clause 5.5)

#### 5.5.1 Organization Chart
```
CEO
│
├── VP Quality & Regulatory
│   ├── Quality Manager
│   ├── Regulatory Affairs Manager
│   └── QA Specialists
│
├── VP Engineering
│   ├── Hardware Engineering Manager
│   ├── Software Engineering Manager
│   └── Design Engineers
│
├── VP Operations
│   ├── Manufacturing Manager
│   ├── Supply Chain Manager
│   └── Production Staff
│
└── VP Clinical & Medical Affairs
    ├── Clinical Research Manager
    └── Medical Director
```

#### 5.5.2 Management Representative
**Name:** [Quality Manager Name]  
**Responsibility:**
- Ensuring QMS processes are established and maintained
- Reporting QMS performance to top management
- Promoting awareness of regulatory and customer requirements

#### 5.5.3 Internal Communication
Methods:
- Weekly staff meetings
- Monthly all-hands meetings
- Quality bulletins
- Document management system
- Email and Slack

### 5.6 Management Review (Clause 5.6)

#### 5.6.1 General
**Procedure:** SOP-003 Management Review

**Frequency:** At least annually (or more frequently if needed)

**Participants:**
- CEO
- VP Quality & Regulatory
- VP Engineering
- VP Operations
- Management Representative

#### 5.6.2 Review Inputs
- Audit results (internal and external)
- Customer feedback and complaints
- Process performance and product conformity
- Status of preventive and corrective actions
- Follow-up from previous reviews
- Changes affecting QMS
- Improvement recommendations
- Regulatory changes
- New or revised customer requirements

#### 5.6.3 Review Outputs
- Improvements to QMS effectiveness
- Improvements to product related to customer requirements
- Resource needs
- Changes to Quality Policy and Objectives

**Record:** Management Review Minutes (FORM-003)

---

## 6. RESOURCE MANAGEMENT

### 6.1 Provision of Resources (Clause 6.1)
Resources determined and provided for:
- Implementation and maintenance of QMS
- Meeting regulatory and customer requirements
- Achieving quality objectives

### 6.2 Human Resources (Clause 6.2)

#### 6.2.1 Competence
**Requirements:**
- Appropriate education, training, skills, and experience
- Competency documented for personnel affecting product quality

#### 6.2.2 Training
**Procedure:** SOP-016 Training

**Training includes:**
- QMS awareness and procedures
- Regulatory requirements (FDA, EU MDR)
- Risk management
- Design controls
- GMP/GDP practices
- Specific job functions

**Records:** Training Matrix (FORM-016)

#### 6.2.3 Awareness
Employees made aware of:
- Relevance and importance of their activities
- How they contribute to quality objectives
- Implications of not conforming to QMS requirements
- Relevant complaints and their potential effect

### 6.3 Infrastructure (Clause 6.3)
Resources provided and maintained:
- **Buildings:** Office and production facility (ISO Class 7 cleanroom)
- **Equipment:** Production equipment, test equipment, IT systems
- **Software:** CAD, PLM, ERP, QMS software
- **Supporting Services:** Calibration, maintenance, IT support

**Maintenance:** Preventive maintenance per schedule (SOP-017)

### 6.4 Work Environment and Contamination Control (Clause 6.4)

#### 6.4.1 General
Work environment managed to ensure product conformity:
- Temperature and humidity controlled
- ESD controls in place
- Cleanroom maintained per ISO 14644-1 (Class 7)
- Personnel hygiene and gowning

#### 6.4.2 Contamination Control
**Controls implemented:**
- Cleanroom protocols
- Material flow control (clean to dirty)
- Personnel training on aseptic techniques
- Environmental monitoring
- Sterile packaging validation

**Procedure:** SOP-018 Environmental Control

---

## 7. PRODUCT REALIZATION

### 7.1 Planning of Product Realization (Clause 7.1)
Product realization planned and developed per:
- Quality objectives and requirements for product
- Need for processes, documents, resources
- Required verification, validation, monitoring, inspection
- Records needed to provide evidence of conformity

**Output:** Product Development Plan (PDP)

### 7.2 Customer-Related Processes (Clause 7.2)

#### 7.2.1 Determination of Requirements
Requirements include:
- Specified by customer (e.g., healthcare facilities)
- Necessary for specified or intended use
- Regulatory requirements (FDA, EU MDR)
- Post-delivery requirements (service, support)

#### 7.2.2 Review of Requirements
Requirements reviewed before commitment to supply.

#### 7.2.3 Communication
Customer communication regarding:
- Product information
- Order handling and changes
- Customer feedback, including complaints
- Advisory notices

### 7.3 Design and Development (Clause 7.3)

**Procedure:** SOP-006 Product Design and Development

#### 7.3.1 Design Planning
**Design and Development Plan includes:**
- Phases and stages of design
- Review, verification, validation activities
- Responsibilities and authorities
- Resource needs
- Risk management activities per ISO 14971

#### 7.3.2 Design Inputs
Requirements defined and recorded:
- Functional and performance requirements
- Regulatory and standards requirements
- Risk management outputs
- Prior similar designs (where applicable)
- User needs and specifications

**Record:** Design Input Specification (DIS)

#### 7.3.3 Design Outputs
Design outputs:
- Meet design input requirements
- Provide information for purchasing, production, service
- Contain or reference product acceptance criteria
- Specify characteristics essential for safe and proper use

**Record:** Design Output Specification (DOS)

#### 7.3.4 Design Review
Reviews conducted at appropriate stages per plan:
- Evaluate ability to meet requirements
- Identify problems and propose actions

**Participants:** Representatives from all affected functions

**Record:** Design Review Minutes

#### 7.3.5 Design Verification
Verification performed per plan:
- Ensure outputs meet input requirements
- Test methods documented

**Methods:**
- Analysis
- Testing (bench, electrical safety, EMC)
- Inspection
- Comparison to similar designs

**Record:** Design Verification Report (DVR)

#### 7.3.6 Design Validation
Validation performed per plan:
- Ensure product meets needs of intended users/uses
- Performed on representative product
- Completed before delivery

**Methods:**
- Clinical investigation
- Usability testing
- Simulated use testing

**Record:** Design Validation Report (DVV)

#### 7.3.7 Design Transfer
Transfer of design outputs to manufacturing:
- Production procedures developed
- Acceptance criteria defined
- Manufacturing capability confirmed

**Record:** Design Transfer Report

#### 7.3.8 Design Changes
All design changes controlled:
- Identified and documented
- Reviewed and approved before implementation
- Evaluated for effect on product and QMS

**Record:** Engineering Change Order (ECO)

#### 7.3.9 Design and Development Files
Design History File (DHF) maintained containing:
- Design plans
- Inputs and outputs
- Verification and validation reports
- Risk management files
- Design reviews
- Design changes

### 7.4 Purchasing (Clause 7.4)

**Procedure:** SOP-008 Purchasing and Supplier Management

#### 7.4.1 Purchasing Process
Purchased product conforms to specified requirements:
- Supplier evaluation and selection
- Type and extent of control per risk and impact
- Supplier performance monitored

**Record:** Approved Supplier List (ASL)

#### 7.4.2 Purchasing Information
Purchase orders include:
- Product specification or reference to specification
- Acceptance criteria
- Quality requirements (e.g., ISO 13485)
- Qualifications of supplier personnel (if applicable)

#### 7.4.3 Verification of Purchased Product
Verification activities include:
- Incoming inspection
- Supplier audits
- Certificate of Conformance/Analysis review

**Record:** Incoming Inspection Record

### 7.5 Production and Service Provision (Clause 7.5)

**Procedure:** SOP-009 Production and Process Controls

#### 7.5.1 Control of Production
Production controlled to ensure conformity:
- Documented procedures and work instructions
- Qualified personnel
- Suitable equipment and environment
- Monitoring and measuring devices
- Defined acceptance criteria

#### 7.5.2 Cleanliness of Product and Contamination Control
Controls implemented per Clause 6.4.2

#### 7.5.3 Installation Activities
Installation instructions provided in IFU:
- Mobile app download and setup
- Device pairing procedure
- Verification of proper operation

**Record:** Installation checklist (if applicable)

#### 7.5.4 Servicing Activities
Service procedures include:
- Software updates
- Troubleshooting
- Repair and return

**Record:** Service Report

#### 7.5.5 Particular Requirements for Sterile Medical Devices
**Sterile Barrier System:**
- Validated per ISO 11607
- Sterility maintained until use
- Shelf life established per ASTM F1980

**Sterilization:**
- EtO sterilization per ISO 11135
- Validation per ISO 11135
- SAL 10⁻⁶ achieved

**Record:** Sterilization Batch Record

#### 7.5.6 Validation of Processes
**Process Validation performed for:**
- Sterilization process
- Software validation
- Cleanroom environmental controls
- Sensor calibration process

**Approach:**
- Installation Qualification (IQ)
- Operational Qualification (OQ)
- Performance Qualification (PQ)

**Revalidation:** Per change control or annually

### 7.6 Control of Monitoring and Measuring Equipment (Clause 7.6)
**See Clause 2.2 for exclusion**

Calibration performed by ISO/IEC 17025 accredited laboratories.

**Calibration records maintained** for:
- Spectrum analyzers
- Multimeters
- Temperature chambers
- Test fixtures

---

## 8. MEASUREMENT, ANALYSIS, AND IMPROVEMENT

### 8.1 General (Clause 8.1)
Monitoring, measurement, analysis, and improvement processes established to:
- Demonstrate product conformity
- Ensure QMS conformity
- Maintain QMS effectiveness

### 8.2 Monitoring and Measurement (Clause 8.2)

#### 8.2.1 Feedback
**Procedure:** SOP-012 Complaint Handling

Feedback system established as early warning of quality issues:
- Customer complaints
- Returns and field actions
- User feedback
- Post-market surveillance data

**Analysis:** Trending and root cause analysis performed

#### 8.2.2 Complaint Handling
All complaints processed per SOP-012:
- Documented and investigated
- Root cause determined
- CAPA implemented if needed
- Regulatory reporting evaluated
- Response provided to customer

**Record:** Complaint Form (FORM-012)

#### 8.2.3 Reporting to Regulatory Authorities
**Procedure:** SOP-013 Medical Device Reporting

Adverse events and field actions reported:
- **FDA:** MDR reports per 21 CFR 803
- **EU:** Vigilance reports per MDR 2017/745
- **Timelines:** Per regulatory requirements (24 hours to 30 days)

#### 8.2.4 Internal Audit
**Procedure:** SOP-004 Internal Audit

**Frequency:** At least annually

**Scope:** All QMS processes and requirements

**Auditors:** Qualified and independent

**Record:** Audit Report (FORM-004)

**Follow-up:** Corrective actions taken and verified

#### 8.2.5 Monitoring and Measurement of Processes
Process performance monitored:
- Production yield
- On-time delivery
- Supplier performance
- CAPA closure rate

**Method:** Key Performance Indicators (KPIs) tracked monthly

#### 8.2.6 Monitoring and Measurement of Product
Product inspected and tested:
- Incoming inspection
- In-process inspection
- Final inspection and testing

**Acceptance:** Product released only after planned activities completed and records approved.

**Record:** Inspection and Test Records (FORM-010)

### 8.3 Control of Nonconforming Product (Clause 8.3)

**Procedure:** SOP-011 Non-Conforming Product

**Disposition:**
- Rework
- Accept under concession (with justification)
- Reject and scrap
- Return to supplier

**Record:** Nonconformance Report (NCR)

**Reworked Product:** Re-inspected to original acceptance criteria

**Regulatory Notification:** If nonconformity could affect safety or regulatory requirements

### 8.4 Analysis of Data (Clause 8.4)
Data analyzed to demonstrate QMS effectiveness and identify improvements:
- Customer feedback
- Product conformity
- Process performance
- Supplier performance

**Methods:** Statistical analysis, trending, Pareto charts

**Output:** Management Review inputs

### 8.5 Improvement (Clause 8.5)

#### 8.5.1 General
Continual improvement pursued through:
- Quality Policy
- Quality Objectives
- Audit results
- Data analysis
- Corrective and preventive actions
- Management Review

#### 8.5.2 Corrective Action
**Procedure:** SOP-005 Corrective and Preventive Action (CAPA)

**Process:**
1. Identify nonconformity
2. Investigate root cause
3. Implement corrective action
4. Verify effectiveness
5. Update risk management

**Record:** CAPA Form (FORM-005)

#### 8.5.3 Preventive Action
**Process:**
1. Identify potential nonconformity
2. Determine causes
3. Implement preventive action
4. Verify effectiveness

**Sources:**
- Risk analysis
- Audit findings
- Data trending
- Industry alerts

**Record:** CAPA Form (FORM-005)

---

## 9. DOCUMENT APPROVAL

This Quality Manual has been reviewed and approved by:

**Prepared by:**  
[Quality Manager Name]  
Quality Manager  
Date: December 1, 2024

**Reviewed by:**  
[Regulatory Affairs Manager Name]  
Regulatory Affairs Manager  
Date: December 1, 2024

**Approved by:**  
[CEO Name]  
Chief Executive Officer  
Date: December 1, 2024

---

**End of Quality Manual**

*This document is controlled. Printed copies are uncontrolled and may not reflect the current revision. Always refer to the electronic QMS for the latest version.*

